Lv1
40 积分 2024-07-24 加入
Are there clinically relevant prognostic factors in diffuse large B-cell lymphoma beyond International Prognostic Index?
5天前
已关闭
CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas
21天前
已完结
Non-Hodgkinʼs Lymphomas Arising in Patients Successfully Treated for Hodgkinʼs Disease
28天前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
1个月前
已完结
From Multi-Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR-T Cell Therapy
1个月前
已完结
Changing role of stem cell transplantation in follicular lymphoma
2个月前
已完结
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
2个月前
已完结
Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma
2个月前
已完结
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells
2个月前
已完结
皖公网安备34019202002308
